S. Rodda

1.5k total citations · 1 hit paper
17 papers, 921 citations indexed

About

S. Rodda is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, S. Rodda has authored 17 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiation and 5 papers in Surgery. Recurrent topics in S. Rodda's work include Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (9 papers). S. Rodda is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (14 papers), Prostate Cancer Treatment and Research (13 papers) and Advanced Radiotherapy Techniques (9 papers). S. Rodda collaborates with scholars based in Canada and United Kingdom. S. Rodda's co-authors include William Morris, Jeremy Hamm, Graeme Duncan, Scott Tyldesley, Michael McKenzie, Howard Pai, Ross Halperin, Nevin Murray, Gerard Morton and Mira Keyes and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

S. Rodda

15 papers receiving 910 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

2016 505 citations William Morris, Scott Tyldesley et al. International Journal of Radiation Oncology*Biology*Physics profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
S. Rodda	837	480	138	107	97	17	921
Theresa Wolfe	742 0.9×	508 1.1×	147 1.1×	200 1.9×	61 0.6×	11	859
Maria Grazia Petrongari	851 1.0×	620 1.3×	120 0.9×	183 1.7×	64 0.7×	27	973
C Marion	660 0.8×	560 1.2×	108 0.8×	219 2.0×	36 0.4×	7	798
Eric E. K. Yeoh	544 0.6×	348 0.7×	163 1.2×	170 1.6×	55 0.6×	13	720
Debra Freeman	669 0.8×	520 1.1×	160 1.2×	138 1.3×	38 0.4×	14	866
Elizabeth O’Meara	617 0.7×	460 1.0×	85 0.6×	229 2.1×	64 0.7×	10	748
Rochelle J. Botten	519 0.6×	345 0.7×	245 1.8×	172 1.6×	93 1.0×	19	763
M. Seke	622 0.7×	438 0.9×	75 0.5×	184 1.7×	43 0.4×	6	737
Biancamaria Saracino	832 1.0×	582 1.2×	192 1.4×	154 1.4×	55 0.6×	24	998
P Althaus	632 0.8×	207 0.4×	137 1.0×	52 0.5×	127 1.3×	26	706

Countries citing papers authored by S. Rodda

Since Specialization

Citations

This map shows the geographic impact of S. Rodda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Rodda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Rodda more than expected).

Fields of papers citing papers by S. Rodda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Rodda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Rodda. The network helps show where S. Rodda may publish in the future.

Co-authorship network of co-authors of S. Rodda

This figure shows the co-authorship network connecting the top 25 collaborators of S. Rodda. A scholar is included among the top collaborators of S. Rodda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Rodda. S. Rodda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Wright, Gavin J., et al.. (2023). Single- and dual-source-strength focal boost planning in low-dose-rate prostate brachytherapy: feasibility study. Journal of Radiotherapy in Practice. 22.

Slevin, Finbar, Samantha Hodgson, S. Rodda, et al.. (2020). Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clinical and Translational Radiation Oncology. 23. 20–26. 21 indexed citations

Slevin, Finbar, S. Rodda, Peter Bownes, et al.. (2019). A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy. Clinical and Translational Radiation Oncology. 20. 1–8. 15 indexed citations

Rodda, S., William Morris, Jeremy Hamm, & Graeme Duncan. (2017). ASCENDE-RT: An Analysis of Health-Related Quality of Life for a Randomized Trial Comparing Low-Dose-Rate Brachytherapy Boost With Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(3). 581–589. 76 indexed citations

Rodda, S., Scott Tyldesley, William Morris, et al.. (2017). ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(2). 286–295. 223 indexed citations

Morris, William, Scott Tyldesley, S. Rodda, et al.. (2016). Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 98(2). 275–285. 505 indexed citations breakdown →

Henry, Ann, S. Rodda, Malcolm Mason, et al.. (2015). The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy. Clinical Oncology. 27(7). 382–386. 5 indexed citations

Bownes, Peter, Hima Bindu Musunuru, S. Rodda, et al.. (2015). Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome. Brachytherapy. 15(1). 40–48. 29 indexed citations

Rodda, S., Scott Tyldesley, Mira Keyes, et al.. (2015). Low-Dose-Rate Prostate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavorable Risk Prostate Cancer: The Results of the ASCENDE-RT Randomized Control Trial. International Journal of Radiation Oncology*Biology*Physics. 93(3). E191–E192. 12 indexed citations

10.

Morris, William, Scott Tyldesley, Howard Pai, et al.. (2015). Low-Dose-Rate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavourable Risk Prostate Cancer: The Results of the ASCENDE-RT* Randomized Control Trial. Brachytherapy. 14. S12–S12. 9 indexed citations

11.

Rodda, S., Stacy Miller, Vincent Lapointe, Jeremy Hamm, & William Morris. (2015). Short Term Androgen Deprivation Therapy Does Not Increase All-Cause Mortality in Men Treated With Low-Dose-Rate Prostate Brachytherapy: A Population-Based Cohort Study. Brachytherapy. 14. S34–S34.

12.

Rodda, S., Scott Tyldesley, & William Morris. (2015). PD-0047: GU and GI toxicity in ASCENDE-RT*: a multicentre randomized trial of dose-escalated radiation for prostate cancer. Radiotherapy and Oncology. 115. S22–S23. 3 indexed citations

13.

Morris, William, Scott Tyldesley, S. Rodda, et al.. (2015). OC-0485: LDR brachytherapy is superior to 78 Gy of EBRT for unfavourable risk prostate cancer: the results of a randomized trial. Radiotherapy and Oncology. 115. S239–S239. 4 indexed citations

14.

Rodda, S., Scott Tyldesley, & William Morris. (2015). Toxicity Outcomes in ASCENDE-RT: A Multicenter Randomized Trial of Dose-Escalation Trial for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S121–S121. 5 indexed citations

15.

Rodda, S., Gillian Duncan, Jeremy Hamm, & William Morris. (2015). Quality of Life Outcomes: ASCENDE-RT a Multicenter Randomized Trial of Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S2–S2. 9 indexed citations

16.

Slevin, Finbar, et al.. (2014). Hyponatraemic seizures following prostate brachytherapy. Journal of Radiotherapy in Practice. 13(3). 371–374. 1 indexed citations

17.

Rodda, S., A.S. Dhadda, P. Dickinson, Abed M. Zaitoun, & E.M. Bessell. (2012). Number of lymph nodes recovered as an independent prognostic factor in predicting outcome in patients with pathologically node-negative rectal cancer following preoperative chemo/radiotherapy.. Journal of Clinical Oncology. 30(4_suppl). 606–606. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact